Skip to main content
. 2022 Jul 11;205:105381. doi: 10.1016/j.antiviral.2022.105381

Fig. 5.

Fig. 5

Analysis ofJMX0286, JMX0301,JMX0941and ML188binding to recombinant SARS-CoV-2 3CLpro: Surface plasmon resonance (SPR). Dose response curve upon titrating 100 μM–0.164 μM for JMX0286 (A), JMX0301 (B) and JMX0941 (C) and ML188 (D) against immobilized 3CLpro. Steady-state affinity model to determine binding affinity (KD) values at equilibrium (E).